Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Remifentanil and Remifentanil-Alfentanil Administration on Emergence Agitation After Brief Ophthalmic Surgery in Children

NCT02486926 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT02486926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Remifentanil and Remifentanil-Alfentanil Administration on Emergence Agitation After Brief Ophthalmic Surgery in Children
Lead sponsor
Hallym University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
January 31, 2014
Enrollment
102 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of other general anesthetics